Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids.
about
Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growthTreatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combinationAnti-Mycobacterium avium activity of quinolones: in vitro activitiesDNA gyrase: structure and function.Inhibition by quinolones of DNA gyrase from Staphylococcus aureus.Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.In vitro cleavable-complex assay to monitor antimicrobial potency of quinolones.Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-124-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro.Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.Norfloxacin binds to human fecal materialIn vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patientsSmall-molecule inhibitors of bacterial AddAB and RecBCD helicase-nuclease DNA repair enzymes.Effects of quinolones on nucleoid segregation in Escherichia coliβ-Cyclodextrin inclusion complex to improve physicochemical properties of pipemidic acid: characterization and bioactivity evaluation.Microbial DNA topoisomerases and their inhibition by antibiotics.Structure-activity relationships of the fluoroquinolones.The 4-quinolone antibiotics: past, present, and future.Mode of action, and in vitro and in vivo activities of the fluoroquinolones.Ciprofloxacin does not inhibit mitochondrial functions but other antibiotics do.DNA gyrase of Staphylococcus aureus and inhibitory effect of quinolones on its activity.Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.In vitro activity of AT-4140 against clinical bacterial isolates.Inhibition of DNA gyrase by optically active ofloxacinMutations producing resistance to norfloxacin in Pseudomonas aeruginosa.Accumulation of enoxacin by Escherichia coli and Bacillus subtilis.Computer automated structure evaluation of quinolone antibacterial agentsNovel quinolone resistance mutations of the Escherichia coli DNA gyrase A protein: enzymatic analysis of the mutant proteins.Curcumin reduces the antimicrobial activity of ciprofloxacin against Salmonella typhimurium and Salmonella typhi.DNA gyrase from the albicidin producer Xanthomonas albilineans has multiple-antibiotic-resistance and unusual enzymatic properties.Absence of cinoxacin-induced DNA fragmentation and mutations in the rat granuloma pouch.Macrolides: problems and promises.
P2860
Q24677043-C1CDBD9F-679D-45E1-A64E-D98BC0ACBE7BQ28361860-FDBA4914-E2C7-419C-A8A5-A820395DE93AQ28378348-F2E65B8F-77DC-4639-879C-81F302DEC4B7Q34507230-EB172D8A-5312-48C4-9F0C-740E45A9AEDAQ34566027-03172116-5AE0-4E02-832D-0728257C2448Q35276315-2A3AC985-3D49-42C1-8220-9686C973FA1DQ35314754-9EE93234-B945-4AEB-93E3-2D7C40C9A326Q35315975-B8B00910-8C38-4DC8-A127-CD2AA693A7CFQ35540188-28F338C9-2409-4362-A0E1-CC79B911954AQ35562756-437FE8FB-C7B3-4D01-A8E6-0C1204F23815Q35566005-20460D9A-8C39-42EC-8B25-F95167F0B7E6Q35823963-C6587070-CE19-481B-99B0-E6CB6EF169B6Q35973388-C2A47CC6-AB25-44FA-A6FD-BE2240396200Q36757605-E622FC48-496D-442E-B4F0-071725B4B551Q37091750-5C47414F-569A-4FE0-95FF-1B4459AEC390Q37885506-E7DBBD3F-4D36-4D7D-8363-C8325D3BB19FQ38629697-B30769E4-AE73-4563-A31C-3CC16F63675FQ39314610-B95B9682-8379-4ABE-B662-AACE1ECCD5FBQ39637667-74D256EB-C395-4C31-B4A3-25DEDBC4513BQ39815263-5113ED30-0B50-41DE-8D9B-777076B7BF5CQ39818650-A73EA4B8-73F6-464D-AC47-B9B27D9D5E96Q39819849-C448EA61-3E46-480C-8CBF-6BA7785A4D49Q39820328-4E03CB0F-452B-451F-BDCD-1EDC2AC8E62FQ39827737-AA4DE0AD-B614-402F-BE55-02084875CC17Q39827996-BC92C4E2-7BC1-45FB-8E99-48F0F1F00B6FQ39828684-FBA64945-D890-4F44-B8DC-90BEAA0EE7ADQ39829116-7D4673CD-F75A-47FD-B45C-9860A48D1C46Q40085874-70A5BDC2-6621-47AC-A69D-C7356A7CAAA6Q40271196-C37A408E-11C5-4EA2-989D-232A4D77E1A9Q43111811-B3173180-867D-4032-B21B-13D968F7D06EQ44681259-DD59094B-DC0F-4ADA-96C2-5B4ACC0A37B5Q54388935-781C43EB-34AB-4CA9-A43E-51A8184E3BE1
P2860
Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Inhibition of Micrococcus lute ...... er quinolone carboxylic acids.
@en
Inhibition of Micrococcus lute ...... er quinolone carboxylic acids.
@nl
type
label
Inhibition of Micrococcus lute ...... er quinolone carboxylic acids.
@en
Inhibition of Micrococcus lute ...... er quinolone carboxylic acids.
@nl
prefLabel
Inhibition of Micrococcus lute ...... er quinolone carboxylic acids.
@en
Inhibition of Micrococcus lute ...... er quinolone carboxylic acids.
@nl
P2860
P356
P1476
Inhibition of Micrococcus lute ...... er quinolone carboxylic acids.
@en
P2093
P2860
P304
P356
10.1128/AAC.29.4.598
P407
P577
1986-04-01T00:00:00Z